Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 81033-513

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 81033-513). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Kesin Pharma Corporation, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-st (Atorvastatin St)

Chemical structure of Atorvastatin Calcium, depicting its molecular framework including functional groups, rings, and calcium ion association with hydration (3H2O).*

FDA Label Image

Atorvastatin-fig-1 (Atorvastatin Fig 1)

A line graph depicting cumulative incidence percentage over 3.5 years for Atorvastatin versus placebo. The Atorvastatin group shows a consistently lower cumulative incidence compared to placebo, with a hazard ratio of 0.64 (95% CI 0.50-0.83) and a p-value of 0.0005, indicating statistical significance.*

FDA Label Image

Atorvastatin-fig-2 (Atorvastatin Fig 2)

A line chart depicting cumulative hazard percentage over time in years, comparing Atorvastatin and placebo groups. The x-axis represents time to first primary endpoint through four years of follow-up, while the y-axis shows cumulative hazard percentage. The graph shows lower cumulative hazard with Atorvastatin versus placebo, and includes a hazard ratio of 0.63 (0.48-0.83) with a p-value of 0.001.*

FDA Label Image

Atorvastatin-fig-3 (Atorvastatin Fig 3)

A line graph comparing the percentage of subjects experiencing a first major cardiovascular event over a 5-year period for Atorvastatin 10 mg and 80 mg doses. The horizontal axis represents time in years, and the vertical axis shows the percentage of subjects. Two lines are shown: a dashed line for 10 mg and a solid line for 80 mg. Hazard ratio (HR) is 0.78 with confidence interval 0.69-0.89 and P-value 0.0002.*

FDA Label Image

Kesin Pharma Logo (Kesin Logo)

FDA Label Image

Atorvastatin Calcium Tablets 20 mg (Atorva Tabs 20mg Carton 100ct Pdp)

Atorvastatin Calcium Tablets USP 20 mg film-coated tablets label for institutional use. The packaging shows 100 unit-dose tablets arranged as 10 packs of 10. Labeler is Kesin Pharma Corporation. NDC 81033-513-01 is visible on the label.*

FDA Label Image

Atorvastatin 40 mg Carton (Atorva Tabs 40mg Carton 100ct Pdp)

Atorvastatin Calcium Tablets USP 40 mg film-coated tablets, labeled for institutional use only. Package contains 100 unit-dose tablets arranged as 10 trays of 10 tablets each. The label shows the NDC 81033-514-01 and is from Kesin Pharma Corporation.*

FDA Label Image

Atovastatin Calcium Tablets 10 mg Carton 100 Count (Atorva Tabs 10mg Carton 100ct)

Packaging label for Atorvastatin Calcium Tablets USP 10 mg by Kesin Pharma Corporation. The label indicates unit-dose tablets in a package of 100 (10 x 10) for institutional use only. It includes storage instructions, dosage form as film-coated tablets, and the NDC code 81033-511-01. Distributed by Kesin Pharma, Oldsmar, FL.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.